Clear health and economical benefits put pressure on hospitals to offer more laparoscopic procedures. This means longer working hours and complexer surgeries, which require better surgical skills and more skilled physicians. Current technological approaches offer assistance at a high financial cost and therefore eliminate the economical benefits. An innovation is needed which offers labour benefits for the surgeon, brings back economical benefits for the hospital, and sustains health benefits for the patient.
Global market for laparoscopic devices is projected to reach €11 billion in 2021. In 2016, the gynaecological surgery instruments segment is estimated to account for the major share of the laparoscopic instruments market. This is owing to laparoscopy being widely used in obstetrics and gynaecology, especially in procedures such as hysterectomy. The market focus for the MIA will be primarily in gynaecological and gastrointestinal procedures. Future applications besides gynaecological and gastrointestinal procedures could include urology and bariatrics. There is a need for Robot Assisted Surgery but current solutions such as the daVinci robot are too expensive or complex for mostly smaller procedures. Although Laparoscopic Surgery is widely accepted and numbers of procedures are growing, there is still a huge potential to grow the number of procedures.
Lapara Surgical offers a device with benefits for patient, surgeon, and hospital. Economical benefits of laparoscopy – reduced infection risks and hospitalisation – are sustained by a mechanical device that does not require the overall costs of current robotic systems. Clinical benefits – shorter, less painful recovery and less scarring – are maintained by a minimally invasive approach. Labour benefits – short learning curve and improved ergonomics – are reached by natural instrument movements and a seated position.